One of the major immune checkpoint pathways is inactivated by the binding of programmed cell-death 1 (PD-1) [7], which is largely expressed on T cells, and its ligand PD-L1 [3,8,9], which is mainly expressed on antigen-presenting cells under physiological conditions but is upregulated on cancer cells [10]. The gene discussed is PDCD1; the disease is cancer.